SEC FORM 4
$2,381,325.86
CRISPR Therapeutics AG (CRSP)
Sale of 47,837 shares at $49.78 per share.
Reporting Person Kulkarni Samarth · Officer Title Chief Executive Officer · Transaction Code S
Traded Oct 19, 2026 · Disclosed Oct 20, 2026
Source: SEC Form 4 · 0001193125-26-426878 · filed 2026-10-20 · View filing →